A Intralipid blocks the entry of the SARS
DOI:
https://doi.org/10.58676/sjmas.v1i3.15Abstract
The effectiveness of Intralipid against SARS-Cov2/COVID/19 with Multiple Organ Dysfunction Syndrome (MODS) prevention or regression is described in the original scientific paper [1]. Intralipid at Oxidative and Nitro-Galogenic stress in patients with SARS-Cov2 / COVID /19, favors the predominance of the membrane-cytoprotective action of Reactive Oxygen Species (ROS) / Reactive Nitrogen Species (ROS/RNS) over the membrane-to-destructive action, restoring the balance between [ROS /AS] / [RNS / ANOS].
References
Vasilieva M. Vasilieva I. Vasiliev I. Groppa S. et al. Intralipid in the Target Treatment of Lipid Peroxidation Disorder Caused by Oxidative and Nitro-Halogenic Stress in Patients with SARS-Cov2/ COVID / 19. Journal of Advances in Medical and Pharmaceutical Sciences. 2020; 22(11): 20-30.
Vasilieva M. Vasilieva I. Vasiliev I. Malakhova M. et al.. Electro - Ion Membrane Distress Syndrome induces Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). J of Clinical Research in Anesthesiology. 2019; 2:2: 1-6.
https://asclepiusopen.com/journal-of-clinical-research-in-anesthesiology/volume-2-issue-2/3.pdf
Cojocaru V. Ceban E. Irina Vasilieva. Maria Vasilieva et al. Successful Resuscitation of Deadly SARS - Cov-2 / COVID19. Bioinformatics & Proteomics Open Access Journal. 2020;4:1
https://medwinpublishers.com/BPOJ/successful-resuscitation-of-deadly-sars-cov2-covid19.pdf
Seyyed Amir Yasin Ahmadi. Mohammad Moradi. Mitra Elmi. Ehsan Bitaraf. et al. Pilot analysis of intravenous lipid infusion role in COVID-19 mortality. Przegla̧d Epidemiologiczny. 2022; 76(2):164-167
LRRC15 leucine rich repeat containing 15. (2023). https://www.ncbi.nlm.nih.gov/gene/131578
Loo L, Waller MA, Moreno CL, Cole AJ, Stella AO, Pop O-T, et al. (2023) Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs. PLoS Biol 21(2): e3001967. https://doi.org/10.1371/journal.pbio.3001967
https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001967
Vasiliev I. Vasilieva M. Vasilieva I. Catereniuc I et al. The extracorporeal bio-xeno perfuzion (myelo-timo-spleen) in multi-organ suportive therapy (MOST) as a energy modulator, for immuno corection compensatory anti-inflamatory respons syndromes, and persistent inflammation, imunno supression, catabolism, and multi organ dysfunction. J Anesth Patient Care. 2015;1:1-5
Vasiliev I. Vasilieva M. Vasilieva I. Catereniuc I et al. Aggressiveness syndrome hyperantiinflammatory immune CHAOS dissonance and extracorporeal myelotimospleen perfusia. Togliatti Medical Council. 2016; 3-4:64-67.
Vasiliev I. Respiratory Support with Alveolar Recruitment for Complex Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome. Book of Abtracts III International Congress for Respiratory Suport Krasnoyarsk. 2009: 2-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Irina Vasilieva, Maria Vasilieva, Ilie Vasiliev
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
